CoChat

The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity

Digomann, David, Kurth, Ina, Tyutyunnykova, Anna, Chen, Oleg, Löck, Steffen, Gorodetska, Ielizaveta, Peitzsch, Claudia, Skvortsova, Ira-Ida, Negro, Giulia, Aschenbrenner, Bertram, Eisenhofer, Graeme, Richter, Susan, Heiden, Stephan, Porrmann, Joseph, Klink, Barbara, Schwager, Christian, Dowle, Adam A., Hein, Linda, Kunz-Schughart, Leoni A., Abdollahi, Amir, Lohaus, Fabian, Krause, Mechthild, Baumann, Michael, Linge, Annett, Dubrovska, Anna · 2019 · Clinical Cancer Research
Cited by 89

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Purpose: The heavy chain of the CD98 protein (CD98hc) is encoded by the SLC3A2 gene. Together with the light subunit LAT1, CD98hc constitutes a heterodimeric transmembrane amino acid transporter. High SLC3A2 mRNA expression levels are associated with poor prognosis in patients with head and neck squamous cell carcinoma (HNSCC) treated with radiochemotherapy. Little is known regarding the CD98hc protein–mediated molecular mechanisms of tumor radioresistance. Experimental Design: CD98hc protein expression levels were correlated with corresponding tumor control dose 50 (TCD50) in HNSCC xenograft models. Expression levels of CD98hc and LAT1 in HNSCC cells were modulated by siRNA or CRISPR/Cas9 gene editing. HNSCC cell phenotypes were characterized by transcription profiling, plasma membrane proteomics, metabolic analysis, and signaling pathway activation. Expression levels of CD98hc and LAT1 proteins were examined by IHC analysis of tumor tissues from patients with locally advanced HNSCC treated with primary radiochemotherapy (RCTx). Primary endpoint was locoregional tumor control (LRC). Results: High expression levels of CD98hc resulted in an increase in mTOR pathway activation, amino acid metabolism, and DNA repair as well as downregulation of oxidative stress and autophagy. High expression levels of CD98hc and LAT1 proteins were significantly correlated and associated with an increase in radioresistance in HNSCC in vitro and in vivo models. High expression of both proteins identified a poor prognosis subgroup in patients with locally advanced HNSCC after RCTx. Conclusions: We found that CD98hc-associated signaling mechanisms play a central role in the regulation of HNSCC radioresistance and may be a promising target for tumor radiosensitization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-18-2951

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 89

Metadata

Authors
Digomann, D., Kurth, I., Tyutyunnykova, A., Chen, O., Löck, S., Gorodetska, I., Peitzsch, C., Skvortsova, I.-I., Negro, G., Aschenbrenner, B., Eisenhofer, G., Richter, S., Heiden, S., Porrmann, J., Klink, B., Schwager, C., Dowle, A. A., Hein, L., Kunz-Schughart, L. A., Abdollahi, A., Lohaus, F., Krause, M., Baumann, M., Linge, A., & Dubrovska, A.
Venue
Clinical Cancer Research
Published
2019-05-15
Volume
25
Issue
10
Pages
3152-3163
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2912008463
Cited by
89
References
4
FWCI
8.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-18-2951
The paper
Digomann, D., Kurth, I., Tyutyunnykova, A., Chen, O., Löck, S., Gorodetska, I., Peitzsch, C., Skvortsova, I.-I., Negro, G., Aschenbrenner, B., Eisenhofer, G., Richter, S., Heiden, S., Porrmann, J., Klink, B., Schwager, C., Dowle, A. A., Hein, L., Kunz-Schughart, L. A., . . . Dubrovska, A. (2019). The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-18-2951

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.